Haybittle et al developed a prognostic index for infiltrating ductal carcinoma based on certain quantitative measures. This was developed at the Nottingham City Hospital and Tenovus Institute for Cancer Research in England.
Parameters:
(1) histologic grade
(2) tumor size in cm
(3) lymph node stage
Lymph Node Stage:
• Based on histological examination of three lymph nodes (low axillary, apical axillary and internal mammary)
• This manner of lymph node examination is not routine in the US.
Parameter |
Finding |
Points |
---|---|---|
histologic grade |
well differentiated |
1 |
|
moderately differentiated |
2 |
|
poorly differentiated |
3 |
lymph node stage |
A (no metastases) |
1 |
|
B (metastases in low axillary lymph node) |
2 |
|
C (metastases in apical axillary and/or internal mammary lymph node) |
3 |
prognostic index =
= (0.2 * (tumor size in cm)) + (points for lymph node stage) + (points for histologic grade)
Interpretation:
• minimum score: just over 2
• maximum score: over 7
Prognostic Index |
Prognosis |
Annual Mortality Rate (in 1980's) |
---|---|---|
< 3.4 |
good |
3% |
3.4 to 5.399 |
moderate |
7% |
>= 5.4 |
poor |
30% |
Purpose: To use the prognostic index of Haybittle et al developed at Nottingham/Tenovus in 1982 for infiltrating ductal carcinoma.
Specialty: Hematology Oncology, Surgery, general, Obstetrics & Gynecology
Objective: severity, prognosis, stage
ICD-10: C50,